ClinicalTrials.govpublic full text
A Study of Genetic and Environmental Factors and Their Effect on Response to Treatment With Lucentis (Ranibizumab) for Wet AMD
macular degeneration, pharmacogenetics, genetics, treatment response, amd, wet amd, age-related macular degeneration, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 915012
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.